Company · CIK 0000203527 · SIC 3845 — Electromedical & Electrotherapeutic Apparatus
VARIAN MEDICAL SYSTEMS INC · VAR
Insider activity reported against this company. All insider holders · Files at: VREX. On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 12, 2018 MForm 4 → | Jan 16, 5:04 pm EST | Kolleen T KennedyEVP and Pres. Oncology Sys. | 1,089 | $67.12 | $73,094 | 27,751 | — | plan? |
| Jan 8, 2018 SForm 4 → | Jan 10, 3:05 pm EST | John W KuoSVP, Gen Counsel and Secretary | 7,991 | $110.65 | $884,200 | 27,361 | −22.6% | plan? |
| Jan 8, 2018 MForm 4 → | Jan 10, 3:05 pm EST | John W KuoSVP, Gen Counsel and Secretary | 7,991 | $73.95 | $590,944 | 35,352 | — | plan? |
| Jan 2, 2018 SForm 4 → | Jan 3, 6:19 pm EST | Timothy E GuertinDirector | 10,000 | $111.46 | $1,114,641 | 65,800 | −13.2% | plan? |
| Dec 18, 2017 SForm 4 → | Dec 18, 9:24 pm EST | Dow R WilsonPresident and CEO, Director | 88,766 | $111.00 | $9,852,935 | 66,776 | −57.1% | plan? |
| Dec 18, 2017 MForm 4 → | Dec 18, 9:24 pm EST | Dow R WilsonPresident and CEO, Director | 88,766 | $60.91 | $5,406,737 | 155,542 | — | plan? |
| Dec 12, 2017 SForm 4 → | Dec 13, 8:41 pm EST | Kolleen T KennedyEVP and Pres. Oncology Sys. | 2,018 | $111.97 | $225,964 | 26,662 | −7.04% | plan? |
| Dec 12, 2017 MForm 4 → | Dec 13, 8:41 pm EST | Kolleen T KennedyEVP and Pres. Oncology Sys. | 2,018 | $73.97 | $149,274 | 27,593 | — | plan? |
| Nov 13, 2017 SForm 4 → | Nov 14, 6:08 pm EST | Kolleen T KennedyEVP and Pres. Oncology Sys. | 2,021 | $107.36 | $216,983 | 26,662 | −7.05% | plan? |
| Nov 13, 2017 MForm 4 → | Nov 14, 6:08 pm EST | Kolleen T KennedyEVP and Pres. Oncology Sys. | 2,021 | $73.98 | $149,505 | 27,750 | — | plan? |
| Oct 18, 2017 SForm 4 → | Oct 19, 8:26 pm EDT | Kolleen T KennedyEVP and Pres. Oncology Sys. | 931 | $105.00 | $97,755 | 26,600 | −3.38% | plan? |
| Oct 18, 2017 MForm 4 → | Oct 19, 8:26 pm EDT | Kolleen T KennedyEVP and Pres. Oncology Sys. | 931 | $81.97 | $76,314 | 27,531 | — | plan? |
| Oct 12, 2017 SForm 4 → | Oct 13, 3:23 pm EDT | Kolleen T KennedyEVP and Pres. Oncology Sys. | 1,088 | $101.55 | $110,489 | 26,600 | −3.93% | plan? |
| Oct 12, 2017 MForm 4 → | Oct 13, 3:23 pm EDT | Kolleen T KennedyEVP and Pres. Oncology Sys. | 1,088 | $67.12 | $73,027 | 27,688 | — | plan? |
| Oct 6, 2017 SForm 4 → | Oct 6, 7:55 pm EDT | R Andrew EckertDirector | 5,651 | $102.39 | $578,594 | 8,999 | −38.6% | plan? |
| Oct 6, 2017 MForm 4 → | Oct 6, 7:55 pm EDT | R Andrew EckertDirector | 5,651 | $62.74 | $354,544 | 14,650 | — | plan? |
| Oct 6, 2017 SForm 4 → | Oct 6, 7:46 pm EDT | Dow R WilsonPresident and CEO, Director | 15,059 | $102.40 | $1,541,978 | 66,776 | −18.4% | plan? |
| Oct 6, 2017 MForm 4 → | Oct 6, 7:46 pm EDT | Dow R WilsonPresident and CEO, Director | 15,059 | $51.23 | $771,473 | 81,835 | — | plan? |
| Sep 13, 2017 MForm 4/A → | Sep 19, 8:40 pm EDT | Kolleen T KennedyEVP and Pres. Oncology Sys. | 933 | $81.97 | $76,478 | 27,533 | — | plan? |
| Sep 13, 2017 SForm 4 → | Sep 14, 11:36 am EDT | Kolleen T KennedyEVP and Pres. Oncology Sys. | 933 | $107.29 | $100,100 | 26,600 | −3.39% | plan? amended |
| Sep 13, 2017 MForm 4 → | Sep 14, 11:36 am EDT | Kolleen T KennedyEVP and Pres. Oncology Sys. | 933 | — | — | 27,533 | — | plan? amended |
| Sep 12, 2017 MForm 4/A → | Sep 19, 8:36 pm EDT | Kolleen T KennedyEVP and Pres. Oncology Sys. | 1,088 | $67.12 | $73,027 | 27,688 | — | plan? |
| Sep 12, 2017 SForm 4 → | Sep 13, 11:25 am EDT | Kolleen T KennedyEVP and Pres. Oncology Sys. | 1,088 | $107.33 | $116,778 | 26,600 | −3.93% | plan? amended |
| Sep 12, 2017 MForm 4 → | Sep 13, 11:25 am EDT | Kolleen T KennedyEVP and Pres. Oncology Sys. | 1,088 | — | — | 27,688 | — | plan? amended |
| Sep 7, 2017 MForm 4/A → | Sep 19, 8:26 pm EDT | Dow R WilsonPresident and CEO, Director | 15,059 | $51.23 | $771,473 | 81,835 | — | plan? |
| Sep 7, 2017 SForm 4 → | Sep 8, 3:05 pm EDT | Dow R WilsonPresident and CEO, Director | 15,059 | $105.41 | $1,587,367 | 66,776 | −18.4% | plan? amended |
| Sep 7, 2017 MForm 4 → | Sep 8, 3:05 pm EDT | Dow R WilsonPresident and CEO, Director | 15,059 | — | — | 81,835 | — | plan? amended |
| Aug 31, 2017 SForm 4 → | Sep 1, 3:48 pm EDT | Kolleen T KennedyEVP and Pres. Oncology Sys. | 931 | $105.00 | $97,755 | 26,600 | −3.38% | plan? |
| Aug 31, 2017 MForm 4 → | Sep 1, 3:48 pm EDT | Kolleen T KennedyEVP and Pres. Oncology Sys. | 931 | $81.97 | $76,314 | 27,531 | — | plan? |
| Aug 17, 2017 GForm 4 → | Aug 21, 5:46 pm EDT | R Andrew EckertDirector | 305 | — | — | 8,999 | — | plan? |
| Aug 14, 2017 SForm 4 → | Aug 15, 7:56 pm EDT | Kolleen T KennedyEVP and Pres. Oncology Sys. | 1,088 | $97.91 | $106,525 | 26,600 | −3.93% | plan? |
| Aug 14, 2017 MForm 4 → | Aug 15, 7:56 pm EDT | Kolleen T KennedyEVP and Pres. Oncology Sys. | 1,088 | $67.12 | $73,027 | 26,600 | — | plan? |
| Aug 7, 2017 SForm 4 → | Aug 8, 8:08 pm EDT | Dow R WilsonPresident and CEO, Director | 15,059 | $96.48 | $1,452,895 | 66,776 | −18.4% | plan? |
| Aug 7, 2017 MForm 4 → | Aug 8, 8:08 pm EDT | Dow R WilsonPresident and CEO, Director | 15,059 | $51.23 | $771,473 | 81,835 | — | plan? |
| Jul 12, 2017 SForm 4 → | Jul 13, 8:08 pm EDT | John W KuoSVP, Gen Counsel and Secretary | 1,597 | $104.43 | $166,780 | 27,361 | −5.51% | plan? |
| Jul 12, 2017 MForm 4 → | Jul 13, 8:08 pm EDT | John W KuoSVP, Gen Counsel and Secretary | 1,597 | $73.95 | $118,091 | 27,361 | — | plan? |
| Jul 12, 2017 SForm 4 → | Jul 13, 7:59 pm EDT | Kolleen T KennedyEVP and Pres. Oncology Sys. | 2,021 | $104.73 | $211,655 | 26,600 | −7.06% | plan? |
| Jul 12, 2017 MForm 4 → | Jul 13, 7:59 pm EDT | Kolleen T KennedyEVP and Pres. Oncology Sys. | 2,021 | $73.98 | $149,505 | 27,533 | — | plan? |
| Jul 10, 2017 SForm 4 → | Jul 11, 7:26 pm EDT | Dow R WilsonPresident and CEO, Director | 15,060 | $103.37 | $1,556,701 | 66,776 | −18.4% | plan? |
| Jul 10, 2017 MForm 4 → | Jul 11, 7:26 pm EDT | Dow R WilsonPresident and CEO, Director | 15,060 | $51.23 | $771,524 | 81,836 | — | plan? |
| Jun 20, 2017 SForm 4 → | Jun 21, 4:49 pm EDT | Kolleen T KennedyEVP and Pres. Oncology Sys. | 26,092 | $105.00 | $2,739,660 | 26,600 | −49.5% | plan? |
| Jun 20, 2017 MForm 4 → | Jun 21, 4:49 pm EDT | Kolleen T KennedyEVP and Pres. Oncology Sys. | 26,092 | $81.97 | $2,138,761 | 52,692 | — | plan? |
| Jun 13, 2017 SForm 4 → | Jun 14, 7:07 pm EDT | John W KuoSVP, Gen Counsel and Secretary | 734 | $101.91 | $74,800 | 27,361 | −2.61% | plan? |
| Jun 13, 2017 MForm 4 → | Jun 14, 7:07 pm EDT | John W KuoSVP, Gen Counsel and Secretary | 734 | $81.97 | $60,166 | 28,095 | — | plan? |
| Jun 12, 2017 SForm 4 → | Jun 13, 7:11 pm EDT | John W KuoSVP, Gen Counsel and Secretary | 863 | $101.25 | $87,378 | 27,361 | −3.06% | plan? |
| Jun 12, 2017 MForm 4 → | Jun 13, 7:11 pm EDT | John W KuoSVP, Gen Counsel and Secretary | 863 | $67.12 | $57,925 | 28,224 | — | plan? |
| Jun 12, 2017 SForm 4 → | Jun 13, 7:07 pm EDT | Kolleen T KennedyEVP and Pres. Oncology Sys. | 1,087 | $101.20 | $110,000 | 26,600 | −3.93% | plan? |
| Jun 12, 2017 MForm 4 → | Jun 13, 7:07 pm EDT | Kolleen T KennedyEVP and Pres. Oncology Sys. | 1,087 | $67.12 | $72,959 | 27,687 | — | plan? |
| Jun 9, 2017 SForm 4 → | Jun 12, 7:48 pm EDT | Timothy E GuertinDirector | 16,000 | $103.22 | $1,651,546 | 75,800 | −17.4% | plan? |
| Jun 8, 2017 SForm 4 → | Jun 9, 4:02 pm EDT | Mark R LaretDirector | 1,428 | $103.47 | $147,761 | 2,161 | −39.8% | plan? |
| Jun 1, 2017 SForm 4 → | Jun 2, 6:59 pm EDT | Kolleen T KennedyEVP and Pres. Oncology Sys. | 56,573 | $99.76 | $5,643,900 | 26,600 | −68.0% | plan? |
| Jun 1, 2017 MForm 4 → | Jun 2, 6:59 pm EDT | Kolleen T KennedyEVP and Pres. Oncology Sys. | 56,573 | $70.63 | $3,995,848 | 83,173 | — | plan? |
| May 31, 2017 SForm 4 → | Jun 1, 3:58 pm EDT | John W KuoSVP, Gen Counsel and Secretary | 19,819 | $99.67 | $1,975,360 | 27,361 | −42.0% | plan? |
| May 31, 2017 MForm 4 → | Jun 1, 3:58 pm EDT | John W KuoSVP, Gen Counsel and Secretary | 19,819 | $81.97 | $1,624,563 | 47,180 | — | plan? |
| May 12, 2017 SForm 4 → | May 12, 6:48 pm EDT | John W KuoSVP, Gen Counsel and Secretary | 862 | $96.39 | $83,084 | 27,361 | −3.05% | plan? |
| May 12, 2017 MForm 4 → | May 12, 6:48 pm EDT | John W KuoSVP, Gen Counsel and Secretary | 862 | $67.12 | $57,857 | 28,223 | — | plan? |
| May 2, 2017 SForm 4 → | May 3, 6:29 pm EDT | Susan L BostromDirector | 3,589 | $91.08 | $326,902 | 3,809 | −48.5% | plan? |
| Apr 12, 2017 SForm 4 → | Apr 13, 7:04 pm EDT | John W KuoSVP, Gen Counsel and Secretary | 864 | $89.74 | $77,533 | 27,050 | −3.10% | plan? |
| Apr 12, 2017 MForm 4 → | Apr 13, 7:04 pm EDT | John W KuoSVP, Gen Counsel and Secretary | 864 | $67.12 | $57,992 | 27,914 | — | plan? |
| Mar 17, 2017 SForm 4 → | Mar 20, 7:38 pm EDT | John W KuoSVP, Gen Counsel and Secretary | 3,876 | $91.75 | $355,623 | 27,050 | −12.5% | plan? |
| Mar 17, 2017 MForm 4 → | Mar 20, 7:38 pm EDT | John W KuoSVP, Gen Counsel and Secretary | 3,876 | $74.06 | $287,057 | 30,926 | — | plan? |
| Mar 13, 2017 SForm 4 → | Mar 14, 8:34 pm EDT | John W KuoSVP, Gen Counsel and Secretary | 862 | $87.89 | $75,758 | 27,050 | −3.09% | plan? |
| Mar 13, 2017 MForm 4 → | Mar 14, 8:34 pm EDT | John W KuoSVP, Gen Counsel and Secretary | 862 | $67.12 | $57,857 | 27,912 | — | plan? |
| Mar 1, 2017 SForm 4 → | Mar 2, 8:04 pm EST | John W KuoSVP, Gen Counsel and Secretary | 10,353 | $84.81 | $878,038 | 27,050 | −27.7% | plan? |
| Mar 1, 2017 MForm 4 → | Mar 2, 8:04 pm EST | John W KuoSVP, Gen Counsel and Secretary | 10,353 | $67.12 | $694,893 | 37,403 | — | plan? |
| Feb 22, 2017 SForm 4 → | Feb 24, 5:10 pm EST | Mark R LaretDirector | 11,302 | $83.56 | $944,408 | 3,589 | −75.9% | plan? |
| Feb 22, 2017 MForm 4 → | Feb 24, 5:10 pm EST | Mark R LaretDirector | 11,302 | $60.01 | $678,177 | 14,891 | — | plan? |
| Feb 21, 2017 MForm 4 → | Feb 22, 5:20 pm EST | Regina E DuganDirector | 2,161 | — | — | 2,161 | — | plan? |
| Feb 21, 2017 MForm 4 → | Feb 22, 5:17 pm EST | David J IllingworthDirector | 2,161 | — | — | 5,134 | — | plan? |
| Feb 21, 2017 MForm 4 → | Feb 22, 5:15 pm EST | Mark R LaretDirector | 2,161 | — | — | 3,589 | — | plan? |
| Feb 21, 2017 MForm 4 → | Feb 22, 5:12 pm EST | Timothy E GuertinDirector | 2,161 | — | — | 2,161 | — | plan? |
| Feb 21, 2017 MForm 4 → | Feb 22, 5:08 pm EST | R Andrew EckertDirector | 2,161 | — | — | 9,304 | — | plan? |
| Feb 21, 2017 MForm 4 → | Feb 22, 5:02 pm EST | Susan L BostromDirector | 2,161 | — | — | 7,398 | — | plan? |
| Feb 15, 2017 FMForm 4 → | Feb 16, 8:52 pm EST | Magnus MomsenSVP, CAO, Corporate Controller | 2,739 | $81.12 | $63,517 | 6,289 | — | plan? |
| Feb 15, 2017 FMForm 4 → | Feb 16, 8:47 pm EST | John W KuoSVP, Gen Counsel and Secretary | 6,683 | $81.12 | $148,450 | 27,050 | — | plan? |
| Feb 15, 2017 FMForm 4 → | Feb 16, 8:44 pm EST | Kolleen T KennedyEVP and Pres. Oncology Sys. | 8,217 | $81.12 | $175,219 | 26,359 | — | plan? |
| Feb 15, 2017 FMForm 4 → | Feb 16, 8:40 pm EST | Elisha W FinneyExec VP and CFO | 7,628 | $81.12 | $162,402 | 10,260 | — | plan? |
| Feb 15, 2017 FMForm 4 → | Feb 16, 8:36 pm EST | Dow R WilsonPresident and CEO, Director | 27,381 | $81.12 | $743,708 | 66,465 | — | plan? |
| Jan 10, 2017 FForm 4 → | Jan 11, 6:55 pm EST | Dow R WilsonPresident and CEO, Director | 6,871 | $89.99 | $618,321 | 57,420 | — | plan? |
| Jan 5, 2017 SForm 4 → | Jan 6, 5:14 pm EST | Dow R WilsonPresident and CEO, Director | 13,334 | $88.74 | $1,183,260 | 64,291 | −17.2% | plan? |
| Jan 5, 2017 MForm 4 → | Jan 6, 5:14 pm EST | Dow R WilsonPresident and CEO, Director | 13,334 | $52.83 | $704,435 | 77,625 | — | plan? |
| Dec 8, 2016 SForm 4 → | Dec 8, 8:32 pm EST | John W KuoSVP, Gen Counsel and Secretary | 1,267 | $90.33 | $114,451 | 24,027 | −5.01% | plan? |
| Dec 5, 2016 SForm 4 → | Dec 5, 9:18 pm EST | Dow R WilsonPresident and CEO, Director | 10,000 | $90.03 | $900,311 | 64,291 | −13.5% | plan? |
| Dec 5, 2016 MForm 4 → | Dec 5, 9:18 pm EST | Dow R WilsonPresident and CEO, Director | 10,000 | $52.83 | $528,300 | 74,291 | — | plan? |
| Nov 21, 2016 FMForm 4 → | Nov 22, 6:48 pm EST | Clarence R VerhoefSVP, Finance, Corp Controller | 1,821 | $89.66 | $42,499 | 5,576 | — | plan? |
| Nov 18, 2016 AFForm 4 → | Nov 21, 7:28 pm EST | Clarence R VerhoefSVP, Finance, Corp Controller | 943 | $88.25 | $22,680 | 4,703 | — | plan? |
| Nov 18, 2016 AFForm 4 → | Nov 21, 7:22 pm EST | John W KuoSVP, Gen Counsel and Secretary | 2,851 | $88.25 | $69,894 | 25,294 | — | plan? |
| Nov 18, 2016 AFForm 4 → | Nov 21, 5:13 pm EST | Kolleen T KennedyEVP and Pres. Oncology Sys. | 3,894 | $88.25 | $93,810 | 22,462 | — | plan? |
| Nov 18, 2016 AFForm 4 → | Nov 21, 5:06 pm EST | Elisha W FinneyExec VP and CFO | 4,177 | $88.25 | $126,374 | 6,636 | — | plan? |
| Nov 18, 2016 AFForm 4 → | Nov 21, 5:03 pm EST | Dow R WilsonPresident and CEO, Director | 11,751 | $88.25 | $355,559 | 64,291 | — | plan? |
| Nov 7, 2016 SForm 4 → | Nov 8, 6:38 pm EST | Dow R WilsonPresident and CEO, Director | 10,000 | $90.59 | $905,907 | 60,598 | −14.2% | plan? |
| Nov 7, 2016 MForm 4 → | Nov 8, 6:38 pm EST | Dow R WilsonPresident and CEO, Director | 10,000 | $52.83 | $528,300 | 70,598 | — | plan? |
| Nov 4, 2016 GForm 4 → | Nov 10, 9:02 pm EST | R Andrew EckertDirector | 727 | — | — | 7,143 | — | plan? late |
| Oct 31, 2016 SForm 4 → | Nov 1, 9:55 pm EDT | Timothy E GuertinDirector | 4,000 | $90.32 | $361,296 | 91,800 | −4.18% | plan? |
| Oct 20, 2016 SForm 4 → | Oct 20, 9:14 pm EDT | John W KuoSVP, Gen Counsel and Secretary | 21,266 | $103.70 | $2,205,284 | 24,027 | −47.0% | plan? |
| Oct 20, 2016 MForm 4 → | Oct 20, 9:14 pm EDT | John W KuoSVP, Gen Counsel and Secretary | 21,266 | $83.70 | $1,779,964 | 45,293 | — | plan? |
| Oct 5, 2016 SForm 4 → | Oct 6, 6:33 pm EDT | Dow R WilsonPresident and CEO, Director | 10,000 | $99.44 | $994,417 | 60,598 | −14.2% | plan? |
| Oct 5, 2016 MForm 4 → | Oct 6, 6:33 pm EDT | Dow R WilsonPresident and CEO, Director | 10,000 | $52.83 | $528,300 | 70,598 | — | plan? |
| Oct 3, 2016 SForm 4 → | Oct 4, 5:19 pm EDT | Elisha W FinneyExec VP and CFO | 4,668 | $98.87 | $461,537 | 5,195 | −47.3% | plan? |
| Oct 3, 2016 MForm 4 → | Oct 4, 5:19 pm EDT | Elisha W FinneyExec VP and CFO | 4,668 | $68.84 | $321,345 | 9,863 | — | plan? |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 10, 2017 MForm 4 → | Jul 11, 7:26 pm EDT | Dow R WilsonPresident and CEO, Director | 15,060 | — | — | 45,177 | — | |
| Jun 20, 2017 MForm 4 → | Jun 21, 4:49 pm EDT | Kolleen T KennedyEVP and Pres. Oncology Sys. | 26,092 | — | — | 7,457 | — | |
| Jun 13, 2017 MForm 4 → | Jun 14, 7:07 pm EDT | John W KuoSVP, Gen Counsel and Secretary | 734 | — | — | 5,879 | — | |
| Jun 12, 2017 MForm 4 → | Jun 13, 7:11 pm EDT | John W KuoSVP, Gen Counsel and Secretary | 863 | — | — | 17,257 | — | |
| Jun 12, 2017 MForm 4 → | Jun 13, 7:07 pm EDT | Kolleen T KennedyEVP and Pres. Oncology Sys. | 1,087 | — | — | 21,759 | — | |
| Jun 1, 2017 MForm 4 → | Jun 2, 6:59 pm EDT | Kolleen T KennedyEVP and Pres. Oncology Sys. | 56,573 | — | — | 0 | — | |
| May 31, 2017 MForm 4 → | Jun 1, 3:58 pm EDT | John W KuoSVP, Gen Counsel and Secretary | 19,819 | — | — | 6,613 | — | |
| May 18, 2017 AForm 4 → | May 19, 6:43 pm EDT | Gary E Bischoping Jr.SVP, Finance & CFO | 83,787 | — | — | 75,330 | — | |
| May 12, 2017 MForm 4 → | May 12, 6:48 pm EDT | John W KuoSVP, Gen Counsel and Secretary | 862 | — | — | 18,120 | — | |
| Apr 12, 2017 MForm 4 → | Apr 13, 7:04 pm EDT | John W KuoSVP, Gen Counsel and Secretary | 864 | — | — | 18,982 | — | |
| Mar 17, 2017 MForm 4 → | Mar 20, 7:38 pm EDT | John W KuoSVP, Gen Counsel and Secretary | 3,876 | — | — | 2 | — | |
| Mar 13, 2017 MForm 4 → | Mar 14, 8:34 pm EDT | John W KuoSVP, Gen Counsel and Secretary | 862 | — | — | 19,846 | — | |
| Mar 1, 2017 MForm 4 → | Mar 2, 8:04 pm EST | John W KuoSVP, Gen Counsel and Secretary | 10,353 | — | — | 20,708 | — | |
| Mar 1, 2017 AForm 4 → | Mar 2, 8:00 pm EST | Jean Luc ButelDirector | 1,871 | — | — | 1,871 | — | |
| Mar 1, 2017 AForm 4 → | Mar 2, 7:57 pm EST | Jose BaselgaDirector | 1,871 | — | — | 1,871 | — | |
| Feb 22, 2017 MForm 4 → | Feb 24, 5:10 pm EST | Mark R LaretDirector | 11,302 | — | — | 0 | — | |
| Feb 21, 2017 MForm 4 → | Feb 22, 5:20 pm EST | Regina E DuganDirector | 2,161 | — | — | 6,326 | — | |
| Feb 21, 2017 MForm 4 → | Feb 22, 5:17 pm EST | David J IllingworthDirector | 2,161 | — | — | 6,326 | — | |
| Feb 21, 2017 MForm 4 → | Feb 22, 5:15 pm EST | Mark R LaretDirector | 2,161 | — | — | 6,326 | — | |
| Feb 21, 2017 MForm 4 → | Feb 22, 5:12 pm EST | Timothy E GuertinDirector | 2,161 | — | — | 6,326 | — | |
| Feb 21, 2017 MForm 4 → | Feb 22, 5:08 pm EST | R Andrew EckertDirector | 2,161 | — | — | 6,326 | — | |
| Feb 21, 2017 MForm 4 → | Feb 22, 5:02 pm EST | Susan L BostromDirector | 2,161 | — | — | 6,326 | — | |
| Feb 15, 2017 MForm 4 → | Feb 16, 8:52 pm EST | Magnus MomsenSVP, CAO, Corporate Controller | 1,956 | — | — | 5,371 | — | |
| Feb 15, 2017 MForm 4 → | Feb 16, 8:47 pm EST | John W KuoSVP, Gen Counsel and Secretary | 4,853 | — | — | 7,253 | — | |
| Feb 15, 2017 MForm 4 → | Feb 16, 8:44 pm EST | Kolleen T KennedyEVP and Pres. Oncology Sys. | 6,057 | — | — | 9,976 | — | |
| Feb 15, 2017 MForm 4 → | Feb 16, 8:40 pm EST | Elisha W FinneyExec VP and CFO | 5,626 | — | — | 4,418 | — | |
| Feb 15, 2017 MForm 4 → | Feb 16, 8:36 pm EST | Dow R WilsonPresident and CEO, Director | 18,213 | — | — | 30,520 | — | |
| Feb 10, 2017 AForm 4 → | Feb 14, 6:29 pm EST | John W KuoSVP, Gen Counsel and Secretary | 20,097 | — | — | 12,106 | — | |
| Feb 10, 2017 AForm 4 → | Feb 14, 6:27 pm EST | Kolleen T KennedyEVP and Pres. Oncology Sys. | 30,220 | — | — | 16,033 | — | |
| Feb 10, 2017 AForm 4 → | Feb 14, 6:25 pm EST | Dow R WilsonPresident and CEO, Director | 90,065 | — | — | 48,733 | — | |
| Feb 10, 2017 AForm 4 → | Feb 14, 6:23 pm EST | Magnus MomsenSVP, CAO, Corporate Controller | 11,583 | — | — | 7,327 | — | |
| Feb 10, 2017 AForm 4 → | Feb 13, 9:16 pm EST | Regina E DuganDirector | 1,990 | — | — | 8,487 | — | |
| Feb 10, 2017 AForm 4 → | Feb 13, 9:14 pm EST | Timothy E GuertinDirector | 1,990 | — | — | 8,487 | — | |
| Feb 10, 2017 AForm 4 → | Feb 13, 9:11 pm EST | David J IllingworthDirector | 1,990 | — | — | 8,487 | — | |
| Feb 10, 2017 AForm 4 → | Feb 13, 9:09 pm EST | Susan L BostromDirector | 1,990 | — | — | 8,487 | — | |
| Feb 10, 2017 AForm 4 → | Feb 13, 9:05 pm EST | R Andrew EckertDirector | 1,990 | — | — | 8,487 | — | |
| Feb 10, 2017 AForm 4 → | Feb 13, 9:02 pm EST | Mark R LaretDirector | 1,990 | — | — | 8,487 | — | |
| Feb 10, 2017 AForm 4 → | Feb 13, 8:58 pm EST | Judy BrunerDirector | 2,870 | — | — | 2,870 | — | |
| Jan 5, 2017 MForm 4 → | Jan 6, 5:14 pm EST | Dow R WilsonPresident and CEO, Director | 13,334 | — | — | 0 | — | |
| Dec 5, 2016 MForm 4 → | Dec 5, 9:18 pm EST | Dow R WilsonPresident and CEO, Director | 10,000 | — | — | 13,334 | — | |
| Nov 21, 2016 MForm 4 → | Nov 22, 6:48 pm EST | Clarence R VerhoefSVP, Finance, Corp Controller | 1,347 | — | — | 4,587 | — | |
| Nov 7, 2016 MForm 4 → | Nov 8, 6:38 pm EST | Dow R WilsonPresident and CEO, Director | 10,000 | — | — | 23,334 | — | |
| Oct 20, 2016 MForm 4 → | Oct 20, 9:14 pm EDT | John W KuoSVP, Gen Counsel and Secretary | 21,266 | — | — | 3,431 | — | |
| Oct 5, 2016 MForm 4 → | Oct 6, 6:33 pm EDT | Dow R WilsonPresident and CEO, Director | 10,000 | — | — | 33,334 | — | |
| Oct 3, 2016 MForm 4 → | Oct 4, 5:19 pm EDT | Elisha W FinneyExec VP and CFO | 4,668 | — | — | 0 | — | |
| Sep 15, 2016 MForm 4 → | Sep 15, 6:42 pm EDT | John W KuoSVP, Gen Counsel and Secretary | 4,073 | — | — | 0 | — | |
| Sep 7, 2016 MForm 4 → | Sep 8, 7:04 pm EDT | Elisha W FinneyExec VP and CFO | 9,000 | — | — | 4,668 | — | |
| Sep 6, 2016 MForm 4 → | Sep 7, 7:52 pm EDT | Dow R WilsonPresident and CEO, Director | 10,000 | — | — | 43,334 | — | |
| Sep 1, 2016 MForm 4 → | Sep 2, 4:52 pm EDT | Elisha W FinneyExec VP and CFO | 2,000 | — | — | 13,668 | — | |
| Aug 22, 2016 MForm 4 → | Aug 23, 4:16 pm EDT | Venkatraman ThyagarajanDirector | 5,748 | — | — | 0 | — | |
| Aug 5, 2016 MForm 4 → | Aug 8, 9:00 pm EDT | Dow R WilsonPresident and CEO, Director | 10,000 | — | — | 53,334 | — | |
| Aug 1, 2016 MForm 4 → | Aug 3, 5:45 pm EDT | Clarence R VerhoefSVP, Finance, Corp Controller | 7,500 | — | — | 0 | — | |
| Aug 1, 2016 MForm 4 → | Aug 3, 5:39 pm EDT | Elisha W FinneyExec VP and CFO | 25,334 | — | — | 15,668 | — | |
| Jul 5, 2016 MForm 4 → | Jul 6, 5:43 pm EDT | Dow R WilsonPresident and CEO, Director | 10,000 | — | — | 63,334 | — | |
| Jun 27, 2016 MForm 4 → | Jun 28, 8:44 pm EDT | Dow R WilsonPresident and CEO, Director | 10,000 | — | — | 73,334 | — | |
| Apr 20, 2016 MForm 4 → | Apr 21, 7:17 pm EDT | Elisha W FinneyExec VP and CFO | 4,000 | — | — | 11,334 | — | |
| Apr 18, 2016 MForm 4 → | Apr 19, 4:47 pm EDT | Clarence R VerhoefSVP, Finance, Corp Controller | 2,500 | — | — | 7,500 | — | |
| Mar 23, 2016 MForm 4 → | Mar 24, 3:56 pm EDT | Dow R WilsonPresident and CEO, Director | 53,000 | — | — | 0 | — | |
| Feb 12, 2016 AMForm 4 → | Feb 17, 6:38 pm EST | Sunny SanyalSVP and President, ICB | 32,861 | — | — | 7,792 | — | |
| Feb 12, 2016 AMForm 4 → | Feb 17, 6:35 pm EST | Clarence R VerhoefSVP, Finance, Corp Controller | 19,836 | — | — | 5,934 | — | |
| Feb 12, 2016 AMForm 4 → | Feb 17, 6:31 pm EST | John W KuoSVP, Gen Counsel and Secretary | 33,662 | — | — | 7,740 | — | |
| Feb 12, 2016 AMForm 4 → | Feb 17, 6:29 pm EST | Kolleen T KennedyEVP and Pres. Oncology Sys. | 42,386 | — | — | 9,717 | — | |
| Feb 12, 2016 AMForm 4 → | Feb 17, 6:26 pm EST | Elisha W FinneyExec VP and CFO | 37,811 | — | — | 8,886 | — | |
| Feb 12, 2016 AMForm 4 → | Feb 17, 6:20 pm EST | Dow R WilsonPresident and CEO, Director | 126,472 | — | — | 29,800 | — | |
| Feb 12, 2016 AMForm 4 → | Feb 17, 3:25 pm EST | Mark R LaretDirector | 3,537 | — | — | 5,748 | — | |
| Feb 12, 2016 AMForm 4 → | Feb 17, 3:24 pm EST | Ruediger Naumann-EtienneDirector | 3,537 | — | — | 5,748 | — | |
| Feb 12, 2016 AMForm 4 → | Feb 17, 3:22 pm EST | R Andrew EckertDirector | 3,537 | — | — | 5,748 | — | |
| Feb 12, 2016 AMForm 4 → | Feb 17, 3:20 pm EST | Susan L BostromDirector | 3,537 | — | — | 5,748 | — | |
| Feb 12, 2016 AMForm 4 → | Feb 17, 3:19 pm EST | David J IllingworthDirector | 3,537 | — | — | 5,748 | — | |
| Feb 12, 2016 AMForm 4 → | Feb 17, 3:17 pm EST | Timothy E GuertinDirector | 3,537 | — | — | 5,748 | — | |
| Feb 12, 2016 AForm 4 → | Feb 17, 3:16 pm EST | Regina E DuganDirector | 2,109 | — | — | 5,748 | — | |
| Feb 12, 2016 AMForm 4 → | Feb 17, 3:13 pm EST | Venkatraman ThyagarajanDirector | 3,537 | — | — | 5,748 | — | |
| Feb 12, 2016 AMForm 4 → | Feb 17, 3:11 pm EST | Erich R ReinhardtDirector | 3,537 | — | — | 5,748 | — | |
| Dec 7, 2015 MForm 4 → | Dec 8, 5:55 pm EST | Dow R WilsonPresident and CEO, Director | 9,000 | — | — | 53,000 | — | |
| Dec 2, 2015 MForm 4 → | Dec 3, 3:55 pm EST | R Andrew EckertDirector | 3,000 | — | — | 0 | — | |
| Nov 23, 2015 MForm 4 → | Nov 25, 3:09 pm EST | Clarence R VerhoefSVP, Finance, Corp Controller | 1,992 | — | — | 4,208 | — | |
| Nov 23, 2015 MForm 4 → | Nov 25, 3:06 pm EST | John W KuoSVP, Gen Counsel and Secretary | 1,937 | — | — | 8,261 | — | |
| Nov 23, 2015 MForm 4 → | Nov 25, 3:03 pm EST | Kolleen T KennedyEVP and Pres. Oncology Sys. | 2,583 | — | — | 10,317 | — | |
| Nov 23, 2015 MForm 4 → | Nov 25, 2:58 pm EST | Elisha W FinneyExec VP and CFO | 2,744 | — | — | 9,645 | — | |
| Nov 23, 2015 MForm 4 → | Nov 25, 2:24 pm EST | Dow R WilsonPresident and CEO, Director | 7,264 | — | — | 31,736 | — | |
| Nov 5, 2015 MForm 4 → | Nov 6, 6:49 pm EST | Dow R WilsonPresident and CEO, Director | 18,000 | — | — | 62,000 | — | |
| Sep 8, 2015 MForm 4 → | Sep 10, 2:56 pm EDT | Dow R WilsonPresident and CEO, Director | 9,000 | — | — | 80,000 | — | |
| Aug 6, 2015 MForm 4 → | Aug 7, 6:50 pm EDT | Dow R WilsonPresident and CEO, Director | 9,000 | — | — | 89,000 | — | |
| Aug 3, 2015 MForm 4 → | Aug 4, 6:02 pm EDT | Elisha W FinneyExec VP and CFO | 2,000 | — | — | 15,334 | — | |
| Jul 6, 2015 MForm 4 → | Jul 7, 3:27 pm EDT | Dow R WilsonPresident and CEO, Director | 9,000 | — | — | 98,000 | — | |
| Jul 2, 2015 MForm 4 → | Jul 7, 1:10 pm EDT | Elisha W FinneyExec VP and CFO | 2,000 | — | — | 17,334 | — | |
| Jul 1, 2015 MForm 4 → | Jul 2, 2:14 pm EDT | Timothy E GuertinDirector | 25,000 | — | — | 0 | — | |
| Jun 5, 2015 MForm 4 → | Jun 8, 6:54 pm EDT | Dow R WilsonPresident and CEO, Director | 9,000 | — | — | 107,000 | — | |
| Jun 1, 2015 MForm 4 → | Jun 2, 8:42 pm EDT | Elisha W FinneyExec VP and CFO | 2,000 | — | — | 19,334 | — | |
| Jun 1, 2015 MForm 4 → | Jun 2, 8:36 pm EDT | Timothy E GuertinDirector | 25,000 | — | — | 25,000 | — | |
| May 6, 2015 MForm 4 → | May 7, 3:36 pm EDT | Dow R WilsonPresident and CEO, Director | 9,000 | — | — | 116,000 | — | |
| May 4, 2015 MForm 4 → | May 6, 3:36 pm EDT | Elisha W FinneyExec VP and CFO | 2,000 | — | — | 21,334 | — | |
| May 4, 2015 MForm 4 → | May 6, 3:32 pm EDT | Timothy E GuertinDirector | 25,000 | — | — | 50,000 | — | |
| Apr 17, 2015 MForm 4 → | Apr 17, 7:09 pm EDT | Dow R WilsonPresident and CEO, Director | 18,760 | — | — | 0 | — | |
| Apr 16, 2015 MForm 4 → | Apr 17, 5:16 pm EDT | Kolleen T KennedyEVP and Pres. Oncology Sys. | 776 | — | — | 5,430 | — | |
| Apr 9, 2015 MForm 4 → | Apr 10, 4:40 pm EDT | John W KuoSVP, Gen Counsel and Secretary | 581 | — | — | 4,073 | — | |
| Apr 1, 2015 MForm 4 → | Apr 2, 7:00 pm EDT | Elisha W FinneyExec VP and CFO | 5,000 | — | — | 23,334 | — | |
| Apr 1, 2015 MForm 4 → | Apr 2, 6:56 pm EDT | Timothy E GuertinDirector | 25,000 | — | — | 75,000 | — | |
| Mar 20, 2015 MForm 4 → | Mar 23, 1:44 pm EDT | Dow R WilsonPresident and CEO, Director | 18,759 | — | — | 18,760 | — | |
| Mar 16, 2015 MForm 4 → | Mar 17, 8:34 pm EDT | Kolleen T KennedyEVP and Pres. Oncology Sys. | 2,327 | — | — | 6,206 | — |
Filed by this entity as an insider elsewhere — common stock
| Trade | Reported (ET) | Company | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 28, 2017 JForm 4 → | Jan 31, 9:12 pm EST | Varex Imaging CorpVREX | 37,386,730 | — | — | 0 | — | plan? |
Filed by this entity as an insider elsewhere — derivatives (options, RSUs, warrants)
No reported derivative activity in this period.